We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drugmakers Ask FDA to Clarify DTC Ad Summary Content Requirements
Drugmakers Ask FDA to Clarify DTC Ad Summary Content Requirements
Drugmakers are urging the FDA to clarify how and why the consumer brief summary in direct-to-consumer print advertisements should differ from FDA-approved patient labeling and medication guides.